Maternal serum irisin levels in early and late-onset pre-eclamptic and healthy pregnancies
暂无分享,去创建一个
H. Erenel | A. Ozel | R. Madazlı | E. Davutoğlu | M. Karslı | Sevim Özge Korkmaz | A. Firat | Asuman Firat
[1] Ai-hua Zhang,et al. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia , 2017, Clinical and experimental hypertension.
[2] X-L Du,et al. Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2016, Hormone and Metabolic Research.
[3] Junfeng Zhang,et al. Lower irisin level in patients with type 2 diabetes mellitus: A case‐control study and meta‐analysis , 2016, Journal of diabetes.
[4] F. Wang,et al. Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms. , 2015, Biochemical and biophysical research communications.
[5] W. Mitch,et al. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues , 2015, International Journal of Obesity.
[6] Xiaodong Sun,et al. The relationship between circulating irisin levels and endothelial function in lean and obese subjects , 2015, Clinical endocrinology.
[7] Soo-Hyun Park,et al. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. , 2015, Cellular signalling.
[8] D. Nelson,et al. Placental pathology suggesting that preeclampsia is more than one disease. , 2014, American journal of obstetrics and gynecology.
[9] N. Çolakoğlu,et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues , 2014, Peptides.
[10] Junxia Zhang,et al. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. , 2014, Atherosclerosis.
[11] M. Oncul,et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. , 2014, Diabetes research and clinical practice.
[12] J. Eslava-Schmalbach,et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. , 2014, The Journal of clinical endocrinology and metabolism.
[13] M. Oncul,et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia , 2014, Archives of Gynecology and Obstetrics.
[14] J. Moreno-Navarrete,et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. , 2013, The Journal of clinical endocrinology and metabolism.
[15] M. Febbraio,et al. Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.
[16] B. Spiegelman,et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.
[17] D. Raymond,et al. A Critical Review of Early-Onset and Late-Onset Preeclampsia , 2011, Obstetrical & gynecological survey.
[18] A. Ragab,et al. Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings? , 2010, Archives of Gynecology and Obstetrics.
[19] S. Hauguel-de Mouzon,et al. The placenta cytokine network and inflammatory signals. , 2006, Placenta.
[20] P. Catalano,et al. Factors that affect maternal insulin resistance and modify fetal growth and body composition. , 2006, Metabolic syndrome and related disorders.
[21] F. Dunne,et al. Oxidative stress and normal pregnancy , 2002, Clinical endocrinology.
[22] J. Roberts,et al. Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.
[23] Diagnosis and management of preeclampsia and eclampsia , 2002 .
[24] M. Ruth. A PGC1–α–dependent myokine that drives brown–fat–like development of white fat and thermogenesis , 2012 .